BIOFRONTERA DISCOVERY GMBH has a total of 23 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CEPBEPE, TEVA GYOGYSZERGYAR ZARTKOERUEN and TEVA GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 3 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | United States | 3 | |
#6 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Sugars | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Climate change adaptation technologies | |
#7 | Fermentation | |
#8 | Acyclic or carbocyclic compounds | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Simon Werner | 12 |
#2 | Hansske Friedrich | 9 |
#3 | Abel Ulrich | 8 |
#4 | Gruen-Wollny Iris | 7 |
#5 | Laatsch Hartmut | 7 |
#6 | Helmke Elisabeth | 5 |
#7 | Paululat Thomas | 4 |
#8 | Sontag Bernd | 4 |
#9 | Maskey Rajendra Prasad | 4 |
#10 | Gerlitz Martin | 2 |
Publication | Filing date | Title |
---|---|---|
WO2005051376A1 | Medicaments containing collybolides | |
DE102004017793A1 | Use of trioxacarcins for treatment and prevention of infectious diseases, also new trioxacarcins for treatment of e.g. tumors, inflammatory and autoimmune diseases | |
DE102004017174A1 | Using cyano-NNO-azoxy compounds as antibacterial, antifungal, antiparasitic and antiviral agents in human or veterinary medicine for treatment of e.g. malaria and tuberculosis | |
DE10356409A1 | New drug oxacheline and derivatives | |
DE10356406A1 | Medicaments with calcium ion channel inhibiting action, useful e.g. for treating hypertension, cardiomyopathy, ataxia, migraine or epilepsy, containing new or known collybolide compounds | |
AU2003270107A1 | Purification method for fredericamycin a | |
US2005215579A1 | Fredericamycin derivatives as medicaments for treating tumours | |
EP1495003A1 | Fredericamycin derivatives | |
CA2480468A1 | Fredericamycin derivatives | |
EP2172457A2 | Fredericamycin derivatives | |
DE10308632A1 | Helicobacter pylori antibiotic | |
DE10248453A1 | Chalcomycin derivatives |